1. Home
  2. YMAB vs TMQ Comparison

YMAB vs TMQ Comparison

Compare YMAB & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • TMQ
  • Stock Information
  • Founded
  • YMAB 2015
  • TMQ 2004
  • Country
  • YMAB United States
  • TMQ Canada
  • Employees
  • YMAB N/A
  • TMQ N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • TMQ Precious Metals
  • Sector
  • YMAB Health Care
  • TMQ Basic Materials
  • Exchange
  • YMAB Nasdaq
  • TMQ Nasdaq
  • Market Cap
  • YMAB 192.4M
  • TMQ 226.7M
  • IPO Year
  • YMAB 2018
  • TMQ N/A
  • Fundamental
  • Price
  • YMAB $4.32
  • TMQ $1.89
  • Analyst Decision
  • YMAB Buy
  • TMQ
  • Analyst Count
  • YMAB 11
  • TMQ 0
  • Target Price
  • YMAB $17.55
  • TMQ N/A
  • AVG Volume (30 Days)
  • YMAB 182.8K
  • TMQ 613.8K
  • Earning Date
  • YMAB 08-11-2025
  • TMQ 07-10-2025
  • Dividend Yield
  • YMAB N/A
  • TMQ N/A
  • EPS Growth
  • YMAB N/A
  • TMQ N/A
  • EPS
  • YMAB N/A
  • TMQ N/A
  • Revenue
  • YMAB $88,658,000.00
  • TMQ N/A
  • Revenue This Year
  • YMAB N/A
  • TMQ N/A
  • Revenue Next Year
  • YMAB $15.15
  • TMQ N/A
  • P/E Ratio
  • YMAB N/A
  • TMQ N/A
  • Revenue Growth
  • YMAB 4.92
  • TMQ N/A
  • 52 Week Low
  • YMAB $3.55
  • TMQ $0.47
  • 52 Week High
  • YMAB $16.11
  • TMQ $2.09
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 43.02
  • TMQ 71.19
  • Support Level
  • YMAB $4.23
  • TMQ $1.30
  • Resistance Level
  • YMAB $4.62
  • TMQ $2.02
  • Average True Range (ATR)
  • YMAB 0.24
  • TMQ 0.12
  • MACD
  • YMAB -0.03
  • TMQ 0.05
  • Stochastic Oscillator
  • YMAB 14.04
  • TMQ 65.97

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

Share on Social Networks: